Comparative In Vitro Activities and Postantibiotic Effects of the Oxazolidinone Compounds Eperezolid (PNU-100592) and Linezolid (PNU-100766) versus Vancomycin against Staphylococcus aureus, Coagulase-Negative Staphylococci, Enterococcus faecalis, and Enterococcus faecium

Benzer Materyaller

• In Vitro Activity of PNU-100766 (Linezolid), a New Oxazolidinone Antimicrobial, against Nocardia brasiliensis
  Yazar:: Vera-Cabrera, Lucio, ve diğerleri
  Baskı/Yayın Bilgisi: (2001)
• Activities of the Oxazolidinones Linezolid and Eperezolid in Experimental Intra-Abdominal Abscess Due to Enterococcus faecalis or Vancomycin-Resistant Enterococcus faecium
  Yazar:: Schülin, T., ve diğerleri
  Baskı/Yayın Bilgisi: (1999)
• In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis.
  Yazar:: Kaatz, G W, ve diğerleri
  Baskı/Yayın Bilgisi: (1996)
• In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species.
  Yazar:: Jorgensen, J H, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents.
  Yazar:: Biedenbach, D J, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)